Carregant...
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
Taxanes are an established option in the standard treatment paradigm for patients with metastatic breast cancer (MBC). Neuropathy is a common, dose-limiting side effect of taxane therapy that is often managed by dose reductions and delays. The severity, time to onset, and improvement in neuropathy a...
Guardat en:
Publicat a: | Cancer Chemother Pharmacol |
---|---|
Autors principals: | , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Springer Berlin Heidelberg
2015
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4365177/ https://ncbi.nlm.nih.gov/pubmed/25596818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-014-2607-5 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|